The antibody is directed against Interleukin 4 (IL-4) but does not inhibit the biological activity of the cytokine. OX-87 is non-competitive with OX-81 (ECACC catalogue no. 95040518) which also reacts with IL-4 but blocks its activity.
| Institute |
|---|
| Medical Research Council; University of Oxford |
| Cat. #: | 156617 |
|---|---|
| Unit size: | 100 ug |
| Target: | Interleukin 4 (IL-4) |
| Reactivity: | Rat |
| Host: | Mouse |
| Class: | Monoclonal |
| Product description: | The antibody is directed against Interleukin 4 (IL-4) but does not inhibit the biological activity of the cytokine. OX-87 is non-competitive with OX-81 (ECACC catalogue no. 95040518) which also reacts with IL-4 but blocks its activity. |
|---|---|
| Conjugation: | Unconjugated |
| Immunogen: | Rat Interleukin 4 |
| Myeloma used: | NS1 |
| Target background: | The antibody is directed against Interleukin 4 (IL-4) but does not inhibit the biological activity of the cytokine. OX-87 is non-competitive with OX-81 (ECACC catalogue no. 95040518) which also reacts with IL-4 but blocks its activity. |
|---|
| Format: | Liquid |
|---|---|
| Shipping conditions: | Dry ice |
| References: |
N/A |
|---|
| Cat. # | Tool Name | |||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 151017 | Anti-MBP [R29.6] |
Key Info
Anti-MBP [R29.6]
|
View Tool | |||||||||||||||||||
| 151021 | Anti-CyclinB1 [V152] |
Key Info
Anti-CyclinB1 [V152]
|
View Tool | |||||||||||||||||||
| 151025 | Anti-Vascular endothelium [10] |
Key Info
Anti-Vascular endothelium [10]
|
View Tool | |||||||||||||||||||
| 151033 | Anti-HSVUL42 [13C9] |
Key Info
Anti-HSVUL42 [13C9]
|
View Tool | |||||||||||||||||||
| 151018 | Anti-Mos [R38.1] |
Key Info
Anti-Mos [R38.1]
|
View Tool | |||||||||||||||||||
Please note we may take up to three days to respond to your enquiry.
CancerTools.org uses the contact information provided to respond to you about our research tools and service. For more information please review our privacy policy.